Eric Grewal, Md, Mmsc
AeroLeads people directory · profile

Eric Grewal, Md, Mmsc Email & Phone Number

Translational Director, Brain Tumor Immunotherapy at Harvard Medical School and Massachusetts General Hospital
Location: Greater Boston, United States, United States 14 work roles 3 schools
1 work email found @mayo.edu LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email e****@mayo.edu
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Translational Director, Brain Tumor Immunotherapy
Location
Greater Boston, United States, United States
Company size

Who is Eric Grewal, Md, Mmsc? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Eric Grewal, Md, Mmsc is listed as Translational Director, Brain Tumor Immunotherapy at Harvard Medical School and Massachusetts General Hospital, a company with 5 employees, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at mayo.edu and a matched LinkedIn profile for Eric Grewal, Md, Mmsc.

Eric Grewal, Md, Mmsc previously worked as Lecturer, Immunology (Cell & Gene Therapy) at Northeastern University and Postdoctoral Fellow, Cellular Immunotherapy at Ragon Institute Of Mass General, Mit, And Harvard. Eric Grewal, Md, Mmsc holds Doctor Of Medicine - Md from Mayo Clinic Alix School Of Medicine.

Company email context

Email format at Harvard Medical School and Massachusetts General Hospital

This section adds company-level context without repeating Eric Grewal, Md, Mmsc's masked contact details.

*@mayo.edu
68% confidence

AeroLeads found 1 current-domain work email signal for Eric Grewal, Md, Mmsc. Compare company email patterns before reaching out.

Profile bio

About Eric Grewal, Md, Mmsc

I am a physician-scientist with expertise in the design, development, and clinical evaluation of innovative immune-based therapies for cancer and immunologic disorders.Over the past decade, I have established myself as a tumor immunologist on the leading edge, conducting impactful research on novel cancer immunotherapies in both academia and industry. My work spans the full spectrum of cancer immunology, including the development of tumor vaccines (peptide, dendritic cell-, microbe-, and neoantigen-based), CAR T cells, innate immune agonists, TCR-based therapies, checkpoint inhibitors, and bispecific T cell engagers. My expertise extends to early clinical development, where I have played key roles in clinical trials of novel immunotherapies for solid tumors. Noteworthy examples include leading a phase I study of a therapeutic tumor vaccine in high-risk melanoma, co-leading biomarker analyses for a prominent phase II combination immunotherapy trial, and conducting histologic analysis for one of the first successful CAR T cell trials for glioblastoma multiforme.In the scientific realm, my research has focused on advancing multiple classes of immunotherapies through mouse models, cell lines, and primary human cells. I have also explored fundamental mechanisms of vaccine response using cutting-edge techniques such as single-cell RNA sequencing, flow cytometry, and in-vitro assays. Through these experiences, I have honed particular expertise in vaccine design, DC-CD8 T cell interactions, antigen-specific immune responses, tolerance mechanisms, and solid tumor immunotherapy.As a board-eligible clinical pathologist, my specialty is in bridging basic science discoveries with patient care. I lead translational projects employing state-of-the art bioinformatics, multiplexed spatial imaging, AI/machine learning, and mass cytometry to investigate tumor biology. I also have formal training in cellular therapy, encompassing apheresis, cellular product processing, and lab directorship.Looking ahead, I am committed to becoming an industry leader in translational research and driving the approval of next-generation immunotherapies. My ultimate goal is to contribute to the development of life-saving treatments for terminally ill patients who are eagerly awaiting new cures.

Listed skills include Python, Microsoft Office, Web Design, Programming, and 7 others.

Current workplace

Eric Grewal, Md, Mmsc's current company

Company context helps verify the profile and gives searchers a useful next step.

Harvard Medical School and Massachusetts General Hospital
Harvard Medical School And Massachusetts General Hospital
Translational Director, Brain Tumor Immunotherapy
Boston, MA, US
Employees
5
AeroLeads page
14 roles

Eric Grewal, Md, Mmsc work experience

A career timeline built from the work history available for this profile.

Lecturer, Immunology (Cell & Gene Therapy)

Current

Boston, MA, US

Teaching faculty for graduate course in Immunology.

Sep 2024 - Present

Postdoctoral Fellow, Cellular Immunotherapy

Current

Cambridge, MA, US

Laboratory of Wilfredo F. García-Beltrán, MD, PhD (Investigations of Natural Killers Lab)Leading the invention, design, and preclinical development of novel antigen-specific T cell-based therapies and best-in-class CAR-NK cell therapies for multiple cancers through in vitro models, cell-based assays, and protein engineering.

Jun 2024 - Present

Clinical Research Fellow, Brain Tumor Immunotherapy

Current

Boston, Massachusetts, US

Laboratory of Bryan Choi, MD, PhD (Dept. of Neurosurgery)Serve as lead pathologist for multiple preclinical investigations of novel antibody- and CAR T cell-based therapies for brain tumors. Oversee histologic and spatial analysis for a phase I trial of a novel CAR T cell for glioblastoma (NCT05660369). Utilize transcriptomics to identify immunologic &.

Jul 2023 - Present

Resident Physician, Clinical Pathology

Current

Boston, Massachusetts, US

Clinical training across Blood Banking/Transfusion Medicine, Coagulation & Benign Hematology, Hematopathology, Clinical Immunology, Molecular Genetics, Clinical Chemistry, Toxicology, Medical Microbiology, HLA & Transplantation. Frequently lead a team of 50+ technologists and lab staff as the on-call physician, providing 24-hour clinical consultation for.

Jun 2022 - Present

Postdoctoral Research Affiliate, Tumor Immunology

Current

Rochester, Minnesota, US

Jun 2022 - Present

Research Scholar, Tumor Immunology

Rochester, Minnesota, US

Laboratory of Matthew S. Block, MD, PhD (Div. of Medical Oncology, Dept. of Immunology)Developed novel peptide, neoantigen, dendritic cell, & HLA-based tumor vaccines for melanoma, including spearheading experiments in preclinical mouse models and assisting phase I clinical development efforts. Led immunologic and serologic biomarker analysis for a phase I.

May 2019 - May 2022

Board Member

Current

Maventibao, MG

Oct 2022 - Present

Clinical Advisor

Current

Maventibao, MG

  • Serve as an advisor in all areas of laboratory medicine at Mada Clinics, a 501(c)(3) non-profit primary care clinic located in rural Northwestern Madagascar.
  • Provide guidance on laboratory test selection, validation, and implementation
  • Help devise testing algorithms that are relevant to the low resource setting
  • Oversee patient data analysis, survey epidemiologic data, and prepare peer-reviewed publications
Sep 2019 - Present

Graduate Student Researcher, Immuno-Oncology

Boston, MA, US

Laboratory of Catherine Wu, MD (Div. of Medical Oncology)Characterized the high-resolution mechanisms of immunity following acute vaccination using single-cell RNA-sequencing. Investigated novel adjuvants (e.g. TLR3, TLR4, STING agonists) across peptide vaccine formulations to develop an ideal platform for tumor neoantigen peptide vaccination. Deployed.

Jan 2017 - Jun 2018

Cancer Immunology Research Intern

Aduro Biotech

Paid research internship at Aduro Biotech, a clinical-stage company developing novel immunotherapies such as Listeria-based vaccines and STING agonists for multiple cancer types. Performed research under Dr. Kelsey Gauthier in the Department of Immunology. Completed multiple DNA sequencing projects on human and animal tissue samples to characterize STING.

Jun 2015 - May 2016

Undergraduate Immunology Researcher

Berkeley, CA, US

Harvested organs from mice immunized with a novel antigen, isolated cells for the production of B cell hybridomas, evaluated growth of antibody-secreting cells to select clones for expansion, and quantified antibody production via assays such as ELISA and IP/SDS-PAGE/Western Blot.Additionally, used DNA manipulation techniques such as PCR, gel.

Jan 2016 - Apr 2016

Systems Microbiology Research Intern

Seattle, Washington, US

  • Paid summer internship at a leading multidisciplinary scientific institute with exposure to research in the areas of microbiology, genomics, systems biology, and science education. Received funding from grants awarded.
  • Studied the growth and genetic pathways of Halobacteria salinarum.
  • Attended daily lectures, seminars, and research presentations related to systems biology.
  • Prepared course materials and developed curriculum modules for a week-long teacher systems biology workshop to promote K-12 STEM education.
  • Gained mentorship and interdisciplinary experience working with biologists, geneticists, physicists, engineers, programmers, and scientific humanities experts.Scientific skills used: bacterial cell culture and growth.
Jul 2013 - Aug 2013
Team & coworkers

Colleagues at Harvard Medical School and Massachusetts General Hospital

Other employees you can reach at northeastern.edu. View company contacts for 5 employees →

3 education records

Eric Grewal, Md, Mmsc education

Doctor Of Medicine - Md

Mayo Clinic Alix School Of Medicine

Master'S Degree, Immunology

Harvard Medical School

Bachelor'S Degree, Immunology & Pathogenesis (Mcb)

University Of California, Berkeley
FAQ

Frequently asked questions about Eric Grewal, Md, Mmsc

Quick answers generated from the profile data available on this page.

What company does Eric Grewal, Md, Mmsc work for?

Eric Grewal, Md, Mmsc works for Harvard Medical School and Massachusetts General Hospital.

What is Eric Grewal, Md, Mmsc's role at Harvard Medical School and Massachusetts General Hospital?

Eric Grewal, Md, Mmsc is listed as Translational Director, Brain Tumor Immunotherapy at Harvard Medical School and Massachusetts General Hospital.

What is Eric Grewal, Md, Mmsc's email address?

AeroLeads has found 1 work email signal at @mayo.edu for Eric Grewal, Md, Mmsc at Harvard Medical School and Massachusetts General Hospital.

Where is Eric Grewal, Md, Mmsc based?

Eric Grewal, Md, Mmsc is based in Greater Boston, United States, United States while working with Harvard Medical School and Massachusetts General Hospital.

What companies has Eric Grewal, Md, Mmsc worked for?

Eric Grewal, Md, Mmsc has worked for Harvard Medical School And Massachusetts General Hospital, Northeastern University, Ragon Institute Of Mass General, Mit, And Harvard, Mayo Clinic, and Mada Clinics.

Who are Eric Grewal, Md, Mmsc's colleagues at Harvard Medical School and Massachusetts General Hospital?

Eric Grewal, Md, Mmsc's colleagues at Harvard Medical School and Massachusetts General Hospital include Yunfan Gao, Marcela De Barros, Tianyi Tao, Kendra Alas, and Zhao Wen.

How can I contact Eric Grewal, Md, Mmsc?

You can use AeroLeads to view verified contact signals for Eric Grewal, Md, Mmsc at Harvard Medical School and Massachusetts General Hospital, including work email, phone, and LinkedIn data when available.

What schools did Eric Grewal, Md, Mmsc attend?

Eric Grewal, Md, Mmsc holds Doctor Of Medicine - Md from Mayo Clinic Alix School Of Medicine.

What skills is Eric Grewal, Md, Mmsc known for?

Eric Grewal, Md, Mmsc is listed with skills including Python, Microsoft Office, Web Design, Programming, Community Service, Research, Pcr, and Science.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.